Acadia Healthcare Company, Inc. (ACHC) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.35	$0.38	+8.6%	—	$865.8M	—
Q1 26	$0.26	$0.37	+42.3%	—	$828.8M	—
Q4 25	$0.01	$0.07	+600.0%	—	$821.5M	—
Q3 25	$0.18	$0.38	+111.1%	—	$851.6M	—
Q2 25	$0.71	$0.83	+16.9%	—	$869.2M	—
Q1 25	$0.36	$0.4	+11.1%	—	$770.5M	—
Q4 24	$0.71	$0.64	-9.9%	—	$774.2M	—
Q3 24	$0.9	$0.91	+1.1%	—	$815.6M	—
Q2 24	$0.88	$0.91	+3.4%	—	$796M	—
Q1 24	$0.8	$0.84	+5.0%	—	$768.1M	—
Q4 23	$0.79	$0.87	+10.1%	—	$742.8M	—
Q3 23	$0.89	$0.91	+2.2%	—	$750.3M	—
Q2 23	$0.86	$0.92	+7.0%	—	$731.3M	—
Q1 23	$0.71	$0.75	+5.6%	—	$704.3M	—
Q4 22	$0.75	$0.7	-6.7%	—	$675.3M	—
Q3 22	$0.79	$1.64	+107.6%	—	$666.7M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$12.2	—	—	$3.3B	—
FY24	—	$2.79	—	—	$3.2B	—
FY23	—	-$0.24	—	—	$2.9B	—
FY22	—	$3.05	—	—	$2.6B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$2.8B	$2.8B	$1.9B	$2B	$2.1B	$2.3B	$2.6B	$2.9B	$3.2B	$3.3B
YoY change	+56.6%	+0.9%	-32.8%	+5.44%	+4.06%	+10.7%	+12.8%	+12.2%	+7.69%	+5.04%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	2.8B	2.8B	1.9B	2B	2.1B	2.3B	2.6B	2.9B	3.2B	3.3B
Cost of revenue	117.4M	114.4M	81.5M	85.5M	87.2M	90.7M	100.2M	106M	112.7M	118M
Gross profit	2.7B	2.7B	1.8B	1.9B	2B	2.2B	2.5B	2.8B	3B	3.2B
Gross margin	95.8%	96%	95.7%	95.7%	95.8%	96.1%	96.2%	96.4%	96.4%	96.4%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	1.8B	1.8B	1.2B	1.3B	1.3B	1.4B	1.6B	1.8B	1.9B	2.1B
Operating expenses	2.1B	2.1B	1.4B	1.5B	1.5B	1.7B	1.9B	2.2B	2.4B	2.6B
Operating income	445.1M	437.9M	305.5M	314.1M	365.6M	414.5M	467.7M	513M	522.3M	388M
Operating margin	15.8%	15.4%	16%	15.6%	17.5%	17.9%	17.9%	17.5%	16.6%	11.7%
Non-operating income, net	-230.9M	-25.1M	-53.6M	-48.4M	-23.7M	-61.7M	-23.8M	-456.3M	-64M	-1.3B
Pretax income	33M	236.8M	67.4M	78.4M	183.8M	275.8M	374.1M	-25.4M	341.9M	-1.1B
Income tax	28.8M	37.2M	9.9M	25.1M	40.6M	67.6M	94.1M	-9.7M	77.4M	26M
Net income	4.2M	199.6M	-175.5M	110.1M	-669.2M	195.6M	280M	-15.7M	264.5M	-1.1B
Net margin	0.15%	7.04%	-9.21%	5.48%	-32%	8.45%	10.7%	-0.53%	8.39%	-33%
EBITDA	580.2M	580.9M	385.9M	402M	460.9M	521.2M	585.5M	645.4M	671.9M	577.2M
EPS	0.07	2.3	-2.01	1.24	-7.65	2.15	3.05	-0.24	2.79	-12.2
Diluted EPS	0.07	2.3	-2.01	1.24	-7.65	2.1	2.98	-0.24	2.78	-12.2

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	750.3M	742.8M	768.1M	796M	815.6M	774.2M	770.5M	869.2M	851.6M	821.5M	828.8M	865.8M
Cost of revenue	27.1M	26.7M	26.7M	27.9M	29.6M	28.6M	28.3M	28.5M	30.4M	30.8M	29.5M	30.2M
Gross profit	723.2M	716.1M	741.4M	768.2M	786M	745.7M	742.2M	840.7M	821.2M	790.7M	799.3M	835.6M
Gross margin	96.4%	96.4%	96.5%	96.5%	96.4%	96.3%	96.3%	96.7%	96.4%	96.3%	96.4%	96.5%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	451.4M	457.6M	475.1M	479.7M	489M	484.8M	502.6M	515M	525.4M	521.2M	532M	541.7M
Operating expenses	551M	553.7M	576.1M	589.4M	601.2M	602.7M	616.6M	649.4M	654.2M	697.3M	663M	697.4M
Operating income	138.8M	127M	128.9M	142.7M	147.2M	103.5M	78.5M	142.3M	119.5M	47.6M	83.8M	87.8M
Operating margin	18.5%	17.1%	16.8%	17.9%	18%	13.4%	10.2%	16.4%	14%	5.8%	10.1%	10.1%
Non-operating income, net	-405.4M	-26.6M	-2.8M	-7.1M	-18.7M	-35.4M	-35.8M	-57.2M	-42.9M	-1.2B	-34.5M	-27.6M
Pretax income	-287.4M	80M	98.8M	106.5M	98.6M	38M	13.5M	50M	40M	-1.2B	11M	22M
Income tax	-71.9M	20.2M	20.1M	25.6M	27.2M	4.5M	4.4M	12.1M	1.7M	7.8M	6.5M	9.7M
Net income	-215.5M	59.8M	78.8M	80.8M	71.4M	33.5M	9.1M	37.9M	38.3M	-1.2B	4.5M	12.3M
Net margin	-28.7%	8.04%	10.3%	10.2%	8.75%	4.33%	1.18%	4.36%	4.5%	-143.3%	0.54%	1.42%
EBITDA	172.2M	162.4M	165.3M	178.8M	184.8M	143M	125.5M	191.3M	167M	93.4M	136.3M	138.2M
EPS	-2.39	0.63	0.84	0.86	0.74	0.36	0.09	0.33	0.4	-13	0.05	0.12
Diluted EPS	-2.39	0.63	0.83	0.85	0.74	0.35	0.09	0.33	0.4	-13	0.05	0.12

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	2.8B	2.2B	2.9B	4.4B	5.4B	7.4B	7.1B	3.6B	1.3B	2.6B
Enterprise value	—	6B	5.4B	6.1B	7.3B	6.9B	8.8B	8.5B	5.6B	3.8B	5.2B
Shares outstanding	85.7M	86.9M	87.3M	87.6M	87.9M	88.8M	89.7M	90.9M	91.6M	90.7M	90.7M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	14.2	—	26.4	—	27.6	26.4	—	13.7	—	20.6
P/S	—	1	1.18	1.45	2.11	2.33	2.83	2.41	1.15	0.39	0.77
P/B	—	1.1	0.96	1.16	2.33	2.09	2.54	2.45	1.14	0.6	1.28
EV/EBITDA	—	10.3	14	15.1	15.8	13.2	15.1	13.1	8.4	6.58	9.8
EV/Sales	—	2.12	2.83	3.02	3.49	2.98	3.38	2.89	1.79	1.15	1.56
Earnings yield	—	7.03%	—	3.78%	—	3.63%	3.79%	—	7.28%	—	4.86%
FCF yield	—	4.42%	7.17%	3.44%	9.82%	2.41%	1.14%	0.54%	-15.4%	-34.2%	-4.04%
PEG	—	—	—	—	—	—	—	—	—	—	-0.32

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	95.8%	96%	95.7%	95.7%	95.8%	96.1%	96.2%	96.4%	96.4%	96.4%	96.5%
Operating margin	15.8%	15.4%	16%	15.6%	17.5%	17.9%	17.9%	17.5%	16.6%	11.7%	10.1%
Net margin	0.15%	7.04%	-9.21%	5.48%	-32%	8.45%	10.7%	-0.53%	8.39%	-33%	-33.4%
ROE	0.19%	7.76%	-7.52%	4.4%	-35.2%	7.57%	9.65%	-0.54%	8.29%	-51%	-41.4%
ROA	0.07%	3.11%	-2.84%	1.6%	-10.3%	4.1%	5.61%	-0.29%	4.44%	-19.8%	3.57%
ROIC	1.04%	6.42%	4.76%	3.77%	5.96%	7.66%	8.08%	12%	7.77%	8.34%	7.39%
Return on tangible assets	0.84%	26.7%	-14.6%	4.28%	-31.1%	85.8%	71.8%	-2.06%	20.5%	-39.8%	-41%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.25	1.25	1.08	1.17	1.93	1.22	1.3	0.67	1	1.55	1.57
Quick ratio	1.23	1.24	1.07	1.16	1.93	1.21	1.29	0.67	0.99	1.54	1.56
Debt / equity	1.52	1.26	1.37	1.3	1.71	0.63	0.53	0.52	0.65	1.24	1.18
Debt / assets	0.55	0.5	0.52	0.47	0.5	0.34	0.31	0.28	0.35	0.48	0.46
Net debt / EBITDA	5.57	5.46	8.14	7.85	6.25	2.89	2.45	2.17	2.99	4.35	4.48
Interest coverage	1.18	2.35	1.37	1.42	2.16	4.58	6.36	0.69	3.94	-6.68	-6.26
Effective tax rate	87.3%	15.7%	14.7%	32%	22.1%	24.5%	25.2%	0%	22.6%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	32.8	32.6	21.8	22.9	23.8	26.1	29.1	32.2	34.4	36.5	37.2
EPS (basic)	0.07	2.3	-2.01	1.24	-7.65	2.15	3.05	-0.24	2.79	-12.2	-12.2
EPS (diluted)	0.07	2.3	-2.01	1.24	-7.65	2.1	2.98	-0.24	2.78	-12.2	-12.4
Book value per share	25.3	29.6	26.7	28.6	21.6	29.1	32.3	31.8	34.8	23.6	21.8
FCF per share	0.63	1.44	1.84	1.14	4.94	1.46	0.94	0.42	-6.12	-4.85	-1.47
Cash per share	0.67	0.77	0.58	1.14	4.31	1.51	1.09	1.1	0.83	1.47	1.84
Capex per share	0.48	0.06	0	0.13	0	0.04	0.08	0.32	0.11	6.3	3.77

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	1.45%	0.19%	0%	0.59%	0%	0.15%	0.27%	1%	0.33%	17.3%	10.2%
Capex / operating cash flow	20.6%	1.26%	0%	7.12%	0.02%	1.11%	1.89%	6.6%	10.4%	433.5%	163.7%
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Yield

—

trailing twelve months

Frequency

Weekly

Last dividend

$0.00

ex-dividend Jun 11, 2014

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jun 11, 2014	$0.00
Jun 5, 2014	$0.00
May 20, 2014	$0.00
May 16, 2014	$0.00
Apr 2, 2014	$0.00

Split history

Date	Ratio
Nov 1, 2011	1:4

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$750.3M	$742.8M	$768.1M	$796M	$815.6M	$774.2M	$770.5M	$869.2M	$851.6M	$821.5M	$828.8M	$865.8M
YoY change	+12.5%	+10%	+9.06%	+8.85%	+8.7%	+4.23%	+0.32%	+9.19%	+4.41%	+6.1%	+7.57%	-0.39%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	57.1M	67.3M	50.5M	99.5M	378.7M	133.8M	97.6M	100.1M	76.3M	133.2M
Receivables	263.3M	296.9M	318.1M	288.9M	273.6M	281.3M	322.4M	361.5M	365.3M	440.6M
Inventory	4.6M	4.8M	5.1M	4.1M	4.9M	4.8M	5.1M	5.3M	5.7M	5.7M
Total current assets	427.9M	471.6M	450.4M	542.2M	2.5B	495M	506.1M	596M	577.5M	814.1M
Property, plant & equipment	989.9M	1.1B	1.1B	521M	450.4M	474.5M	289.5M	320M	645.5M	372.1M
Goodwill & intangibles	5.5B	5.7B	5B	4.3B	4.3B	4.5B	4.6B	4.6B	4.7B	2.8B
Total assets	6B	6.4B	6.2B	6.9B	6.5B	4.8B	5B	5.4B	6B	5.5B
Accounts payable	80M	102.3M	117.7M	90.3M	87.8M	98.6M	104.7M	156.1M	232.7M	150.4M
Short-term debt	34.8M	34.8M	34.1M	65.6M	204.6M	42.9M	48.7M	56.5M	103.4M	50.7M
Total current liabilities	342.9M	377.4M	416.4M	463.6M	1.3B	404.9M	388.3M	885.8M	577.9M	525.2M
Long-term debt	3.3B	3.2B	3.2B	3.2B	3.1B	1.6B	1.5B	1.4B	2B	2.6B
Total liabilities	3.9B	3.9B	3.8B	4.4B	4.6B	2.2B	2.1B	2.5B	2.8B	3.4B
Shareholders' equity	2.2B	2.6B	2.3B	2.5B	1.9B	2.6B	2.9B	2.9B	3.2B	2.1B
Total debt	3.3B	3.2B	3.2B	3.3B	3.3B	1.6B	1.5B	1.5B	2.1B	2.6B
Net debt	3.2B	3.2B	3.1B	3.2B	2.9B	1.5B	1.4B	1.4B	2B	2.5B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	99.6M	100.1M	77.3M	77.2M	82.1M	76.3M	91.2M	131.4M	118.7M	133.2M	158.5M	171.3M
Receivables	362.7M	361.5M	386.2M	389.4M	383.9M	365.3M	396.6M	408.5M	430.8M	440.6M	471.8M	470.8M
Inventory	5.5M	5.3M	5.7M	6M	5.5M	5.7M	5.7M	5.8M	6.2M	5.7M	5.9M	6.3M
Total current assets	703.5M	596M	610.8M	645.2M	652.1M	577.5M	639M	691.6M	748M	814.1M	837.2M	845.3M
Property, plant & equipment	270.2M	320M	408.9M	515.7M	678.9M	645.5M	542.8M	600.8M	425.4M	372.1M	330.9M	83M
Goodwill & intangibles	4.6B	4.6B	4.7B	4.7B	4.7B	4.7B	4.7B	4.7B	4.7B	2.8B	2.8B	2.8B
Total assets	5.3B	5.4B	5.5B	5.7B	5.9B	6B	6.1B	6.3B	6.4B	5.5B	5.5B	5.5B
Accounts payable	149.9M	156.1M	156.1M	159.5M	201.4M	232.7M	204M	219.8M	179.9M	150.4M	142.2M	135.3M
Short-term debt	53.8M	56.5M	89.3M	94.6M	100M	103.4M	42.2M	44M	46.9M	50.7M	54.3M	54.3M
Total current liabilities	864.9M	885.8M	482.3M	546.5M	609.5M	577.9M	473.4M	523.7M	517.9M	525.2M	489.4M	537.6M
Long-term debt	1.5B	1.4B	1.9B	1.9B	1.9B	2B	2.3B	2.3B	2.4B	2.6B	2.6B	2.5B
Total liabilities	2.5B	2.5B	2.5B	2.6B	2.7B	2.8B	3B	3.1B	3.1B	3.4B	3.4B	3.4B
Shareholders' equity	2.8B	2.9B	3B	3.1B	3.1B	3.2B	3.2B	3.2B	3.3B	2.1B	2.2B	2.2B
Total debt	1.5B	1.5B	2B	2B	2B	2.1B	2.3B	2.4B	2.4B	2.6B	2.7B	2.6B
Net debt	1.4B	1.4B	1.9B	1.9B	1.9B	2B	2.2B	2.3B	2.3B	2.5B	2.5B	2.4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	4.2M	199.6M	-175.5M	110.1M	-669.2M	195.6M	280M	-15.7M	264.5M	-1.1B
Depreciation & amortization	135.1M	143M	80.3M	87.9M	95.3M	106.7M	117.8M	132.3M	149.6M	189.2M
Stock-based compensation	28.3M	23.5M	22M	17.3M	22.5M	37.5M	29.6M	32.3M	37.1M	31.7M
Change in working capital	-13.4M	-639K	17.8M	-10.4M	173.1M	-53.3M	-76.2M	-9.9M	-418M	-35.3M
Operating cash flow	197.9M	418.1M	215.9M	165.2M	500.9M	315.5M	373.8M	445.8M	100.3M	131.9M
Capital expenditure	-40.8M	5.3M	0	11.8M	92K	3.5M	7.1M	29.4M	10.4M	-571.8M
Investing cash flow	-353.4M	-21.3M	-4.2M	-20.2M	-13.3M	1.3B	-9.7M	26.9M	-46.1M	-580.1M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	-8.8M	-3.5M	-3.4M	-1.6M	—	—	—	—	—	-50M
Financing cash flow	192M	-63.5M	-64.2M	-60.8M	-48.1M	-1.5B	-110.9M	-62.7M	583M	481.3M
Net change in cash	36.5M	333.2M	147.5M	84.2M	439.5M	191.7M	253.2M	410M	637.2M	33.1M
Free cash flow	54M	125.4M	160.9M	100.2M	433.8M	129.7M	84.4M	38.2M	-560.7M	-439.9M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	-215.5M	59.8M	78.8M	80.8M	71.4M	33.5M	9.1M	37.9M	38.3M	-1.2B	4.5M	12.3M
Depreciation & amortization	33.4M	35.4M	36.3M	36.1M	37.6M	39.5M	47M	49M	47.5M	45.8M	52.4M	50.4M
Stock-based compensation	8.2M	9.1M	8.7M	8.9M	9.5M	10.1M	8.7M	10.5M	6M	6.5M	8M	11M
Change in working capital	-67.9M	70.8M	-434.5M	5.2M	9.4M	1.9M	-33.8M	28.3M	-41.8M	11.9M	20.5M	53.8M
Operating cash flow	131.4M	105.4M	-296.3M	153.6M	146M	96.9M	30M	124.9M	73.2M	-86.3M	61.5M	162.1M
Capital expenditure	12K	28.8M	9.1M	1.2M	18K	208K	43K	16.6M	-136.2M	-93.2M	-76.6M	-38.6M
Investing cash flow	-1.3M	28.6M	-42.2M	-1.2M	-2.8M	164K	-8.6M	17M	-136.3M	-93.1M	-76.6M	-42.8M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	-46.9M	-3.2M	0	0	0	0
Financing cash flow	-36.1M	-5.7M	483.1M	-15.8M	34.9M	80.8M	186.7M	57.5M	43.8M	193.3M	23.9M	-116.6M
Net change in cash	94.1M	128.3M	144.7M	136.6M	178.1M	177.9M	208.1M	199.3M	-19.3M	13.9M	8.8M	2.7M
Free cash flow	9.8M	-22.4M	-463.7M	16.9M	-27.1M	-86.8M	-163.2M	-34.2M	-63M	-179.5M	-15M	123.5M

Acadia Healthcare Company, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Split history

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement